Published: January 2023
With growing applications of DNA in medical research, industry stakeholders are actively looking for technologies that not only facilitate parallelized synthesis of DNA but also provide unmatched precision, scalability, and speed
With an increased focus on automating DNA synthesis technologies, several developers have incorporated robust automatic techniques that enable the engineering of biological systems and study genome in a high throughput manner. This further leads to an increase in the yield of high-fidelity DNA fragments for use across several drug discovery and drug development processes
To order this 290+ page report, which features 130+ figures and 100+ tables, please visit this link
Currently, more than 65 technology / service providers claim to offer DNA synthesis technologies and services
Majority of the stakeholders (53%) in this market claim to offer DNA synthesis services. A large proportion (56%) of these companies are small players, followed by mid-sized (28%) and large firms (18%).
Partnership activity within this domain has increased between 2017-2022
During the given time period, acquisition (40%) was the most common type of partnership model adopted by the companies involved in the DNA synthesis technologies and services domain. This was followed by technology licensing deals (20%), manufacturing (9%), product development (9%) and platform development agreements (6%).
Over USD 800 million has been invested by both private and public investors, since 2017
Of the total, close to USD 580 billion was raised through venture capital financing, representing around 40% of the overall investment. On the other hand, instances (29%) of grants were also reported, wherein players collectively raised more than USD 40 million.
Close to 1,300 articles related to DNA synthesis technologies and services, have been published in reputed scientific journals, since 2017
It is worth highlighting that more than 1,000 publications were related to research related information specific to DNA synthesis technologies and services; majority (36%) of these articles were published in North America.
1,000+ patents related to DNA synthesis technologies have been granted / filed by stakeholders, across the globe
Over the years, the annual number of patent applications filed in this domain has increased from 41 patent applications in 2017 to 70 patents in 2021. Interestingly, 70% of the patents in the domain were filed by industry players.
North America is anticipated to capture larger share of the market by 2035
In terms of the method of DNA synthesis, the major share is captured by chemical method of DNA synthesis and the trend is unlikely to change in the foreseen future. Further, among the application areas, research and diagnostic applications are likely to hold the greater market share.
To request a sample copy / brochure of this report, please visit this link
The financial opportunity within the DNA synthesis services market has been analyzed across the following segments:
The report features inputs from eminent industry stakeholder(s), who were very optimistic concerning the adoption of DNA synthesis technologies and services.
The report includes profiles of key players (listed below) engaged in the DNA synthesis technologies and services domain; each profile features a tabulated overview of company, product / service portfolio, recent developments, and an informed future outlook.
For additional details, please visit https://www.rootsanalysis.com/reports/dna-synthesis-market.html or email email@example.com
You may also be interested in the following titles:
+1 (415) 800 3415
+44 (122) 391 1091
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES